MRSA Initiative research calls for second look at cost-effectiveness

Though initiatives meant to prevent hospital-acquired infection come with price tags that can seem to outweigh the reduction of a single infectious disease, a new study published by Drs. Michihiko Goto and Eli Perencevich in a recent issue of Clinical Infectious Disease shows that the benefits of such initiatives may be far-reaching. (Our initial announcement […]

Positive Collateral Damage in MRSA Fight

Drs. Michihiko Goto and Eli Perencevich have published new findings in the most recent issue of Clinical Infectious Disease that reveal the VA’s nationwide and successfully aggressive effort to decrease drug-resistant staph infections had the added benefit of dramatically reducing infection rates of even more difficult-to-fight bacteria. The VA’s efforts at increasing hand hygiene practice, […]